Abu Fahad Abbasi

ORCID: 0000-0003-2539-2250
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease Diagnosis and Treatment
  • Vaccine Coverage and Hesitancy
  • COVID-19 Clinical Research Studies
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease and Transplantation
  • SARS-CoV-2 detection and testing
  • Gastroesophageal reflux and treatments
  • Pancreatitis Pathology and Treatment
  • Vasculitis and related conditions
  • Virology and Viral Diseases
  • Respiratory viral infections research
  • Liver Diseases and Immunity
  • COVID-19 Pandemic Impacts
  • Folate and B Vitamins Research
  • Influenza Virus Research Studies
  • Esophageal and GI Pathology
  • Systemic Sclerosis and Related Diseases
  • Gastrointestinal disorders and treatments
  • Vascular Tumors and Angiosarcomas
  • Gastric Cancer Management and Outcomes
  • Viral gastroenteritis research and epidemiology
  • Dermatological and Skeletal Disorders
  • Head and Neck Cancer Studies
  • Immune responses and vaccinations

Loyola University Medical Center
2021-2024

Mercy Health
2024

UConn Health
2022

Edward Hines, Jr. VA Hospital
2022

Loyola University Chicago
2022

Golestan University of Medical Sciences
2015

Golestan University
2015

In the United States, Pfizer-BioNTech, Moderna, and Janssen's coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with Pfizer-BioNTech vaccine presently approved by US Food Drug Administration. The purpose of this study is to analyze passive surveillance data on COVID-19 adverse reaction in States.We analyzed reactions which were retrieved from Vaccine Adverse Event Reporting System database. Retrieved records demographic information as well top...

10.7774/cevr.2022.11.1.104 article EN cc-by-nc Clinical and Experimental Vaccine Research 2022-01-01

10.14309/01.ajg.0001043992.30438.87 article EN The American Journal of Gastroenterology 2024-10-01

Among the patients who present to emergency room or a primary care office with symptoms of dysphagia, chest pain, and reflux, approximately 9% have an underlying rheumatological condition. It is not surprising that many internal medicine clinicians frequently overlook this etiology investigate other causes first. However, overwhelming number conditions (61.1%) some form esophageal dysmotility ranges from ineffective motility (IEM) achalasia. We case systemic lupus erythematosus (SLE) absent...

10.7759/cureus.23208 article EN Cureus 2022-03-16
Coming Soon ...